FDA Decision Spurs Estrogen Patch Shortage Amid Rising Demand
The United States is experiencing a shortage of estrogen patches, a key treatment for menopause symptoms, following a surge in demand. This increase began after the U.S. Food and Drug Administration (FDA) removed a long-standing warning about dementia, cardiovascular disease, and breast cancer from the medication. Estrogen patches, which deliver hormones through the skin, are considered the most effective treatment for menopause symptoms and also help protect against osteoporosis and aid mood and memory. The shortage has been exacerbated by a 26% increase in demand, as reported by Truveta. Celebrities like Amy Schumer have raised awareness about the issue, advising women to seek alternative forms of estrogen therapy. 
